The New York Mets have used the No. 27 overall pick in the 2026 MLB Draft on Carson Wiggins, taking a pitcher whose talent had already made him one of the most intriguing names in the class. For Arkansas, it is a reminder of just how high the ceiling was on a player it had hoped to get back for a redshirt sophomore season in 2027.
Wiggins did not pitch during his sophomore season after undergoing Tommy John surgery in May 2025, but he was declared 100% healthy earlier this spring. That combination of medical uncertainty and obvious upside made him a fascinating draft case, and the Mets decided the upside was worth the gamble.
Why Carson Wiggins stood out
The appeal is obvious when you look at the raw stuff. Wiggins has touched 102 mph, with his fastball previously reaching 98 mph, and that kind of arm strength is the sort of trait that can push a pitcher into first-round consideration even after an injury setback.
Before the surgery, he had the profile of a high-end SEC arm. The expectation around Arkansas was that, if he returned, he could develop into a Friday night starter, which tells you how highly the program valued his potential.
What this means for Arkansas
Arkansas had reasons to believe Wiggins might have been back in Fayetteville for 2027, but the No. 27 selection changes that picture quickly. He now leaves college with unfinished business, having worked through the recovery process and only now getting the chance to move on to the next level.
The numbers from his freshman year still help explain the interest. Wiggins went 1-1 with three saves and a 3.21 ERA across 14 innings, striking out 20 while walking nine. It is a small sample, but it offered enough evidence for a club to dream on the arm strength and the strikeout ability.
For the Mets, this is the sort of pick that balances risk and upside. For Arkansas, it is another reminder that when a pitcher can throw 102 mph and is back to full health, he rarely stays available for long.
